Protective effect of resveratrol against 6-hydroxydopamine-induced impairment of renal p-aminohippurate transport

Archives of Toxicology

Volumn 78, Issue 9, 2004, Pages 525-532

  Cojocel, C ^a   Thomson, M S ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

6 Hydroxydopamine; Nephrotoxicity; p Aminohippurate transport; Resveratrol

Indexed keywords

4 AMINOHIPPURIC ACID; CEFALORIDINE; CISPLATIN; OXIDOPAMINE; PROBENECID; RESVERATROL; TETRYLAMMONIUM;

ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CELL MEMBRANE TRANSPORT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; KIDNEY CORTEX SLICE; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE DAMAGE; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RAT; RENAL PROTECTION; TIME;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL TRANSPORT; CEPHALORIDINE; CISPLATIN; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; KIDNEY CORTEX; MALE; OXIDOPAMINE; P-AMINOHIPPURIC ACID; RATS; RATS, SPRAGUE-DAWLEY; STILBENES;

ANIMALIA;

EID: 5344259674     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-004-0566-z     Document Type: Article

References (59)

1. Andrew R, Watson DG, Best SA, Midgley JM, Wenlong H, Petty RK (1993) The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls. Neurochem Res 18:1175-1177
2. Appenroth D, Braunlich H (1981) Effect of sympathectomy with 6-hydroxydopamine on the renal excretion of water and electrolytes in developing rats. Acta Biol Med Ger 40:1715-1721
3. Bertelli AA, Giovannini L, Stradi R, Urien S, Tillement JP, Bertelli A (1996) Kinetics of trans- and cis-resvertrol (3,4′,5-trihydroxystilbene) after red wine oral administration in rats. Int J Clin Pharmacol Res 16:77-81
4. Bertelli AA, Migliori M, Panichi V, Origlia N, Filippi C, Das DK, Giovannini L (2002) Resveratrol, a component of wine and grapes, in the prevention of kidney disease. Ann N Y Acad Sci 957:230-238
5. Beuter W, Cojocel C, Muller W, Donaubauer HH, Mayer D (1989) Peroxidative damage and nephrotoxicity of dichlorovinylcysteine in mice. J Appl Toxicol 9:181-186
6. Braunlich H, Rossler S, Gerhardt S (1993) Influence of sympathetic nervous system on dexmethasone-stimulated renal tubular transport of p-aminohippurate in young rats. Dev Pharmacol Ther 20:86-92
7. 3. Free Radic Biol Med 26:1531-1537
8. Cohen G, Heikkila RE (1974) The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J Biol Chem 249:2447-2452
9. Cojocel C (1990) Biochemical aspects of the renal tolerance for cefpirome and other cephalosporins. Arzneimittelforschung 40:1140-1144
10. Cojocel C, Lock EA (1999) The kidney. In: Marquardt HH, Schaefer SG, McClellan R, Welsch F (eds) Toxicology. Academic Press, San Diego, pp 297-330
11. Cojocel C, Hannemann J, Baumann K (1985) Cephaloridine-induced lipid peroxidation initiated by reactive oxygen species as a possible mechanism of cephaloridine nephrotoxicity. Biochim Biophys Acta 834:402-410
12. Cojocel C, Göttsche U, Tölle K-L, Baumann K (1988) Nephrotoxic potential of first-, second-, and third-generation cephalosporins. Arch Toxicol 62:458-464
13. Cross RJ, Tagart JV (1950) Renal tubular transport: accumulation of p-aminohippurate by rabbit kidney slices. Am J Physiol 161:181-190
14. Fauconneau B, Waffo-Teguo P, Huguet F, Barrier L, Decendi A, Merillon JM (1997) Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci 61:2103-2110
15. Giovannini L, Migliori M, Longoni BM, Das DK, Bertelli AA, Panichi V, Filippi C, Bertelli A (2001) Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys. J Cardiovasc Pharmacol 37:262-270
16. Glinka Y, Gassen, M, Youdim MB (1997) Mechanism of 6-hydroxydopamine neurotoxicity. J Neural Transm Suppl 50:55-66
17. Hannemann J, Baumann K (1988) Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: different effects of antioxidant and radical scavengers. Toxicology 51:119-132
18. Hannemann J, Wunderle W, Baumann K (1992) Nephrotoxicity of acyclovir and cis-diamminedichloroplatinum(II)-effect of coadministration in rats. J Cancer Clin Oncol 118:181-186
19. He Y, Lee T, Leong SK (2000) 6-Hydroxydopamine induced apoptosis of dopaminergic cells in the rat substantia nigra. Brain Res 858:163-166
20. Hirsch EC (1993) Does oxidative stress participate in nerve cell death in Parkinson's disease? Eur Neurol 33 [Suppl 1]:52-59
21. Ho AK, McLaughlin R, Chan A, Duffield R (1999) 6-Hydroxydopamine induced cardiac malformations and alterations of the autonomic nervous system in the developing chicken embryo. Jpn J Pharmacol 81:38-47
22. Jameson GNL, Linert W (2000) 6-Hydroxydopamine, dopamine, and ferritin: a cycle of reactions sustaining Parkinson's disease? In: Poli G, Cadenas E, Packer L (eds) Free radicals in brain pathophysiology. Marcel-Decker, New York, pp 247-272
23. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Fansworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218-220
24. Jankovic J (2001) Parkinson's disease therapy: treatment of early and late disease. Chin Med J (Engl) 114:227-234
25. Jenner P, Olanow CW (1996) Oxidative stress and the pathogenesis of the Parkinson's disease. Neurology 47 [Suppl 3]:S161-S170
26. Jenner WN, Rose FA (1974) Dopamine 3-O-sulphate, an end product of L-dopa metabolism in Parkinson disease. Nature 252:237-238
27. Kinzel E, Jellinger K, Stachelberger H, Linert W (1999) Iron as catalyst for oxidative stress in the pathogenesis of Parkinson's disease? Life Sci 65:1973-1976
28. Kramer W, Cojocel C, Mayer D (1990) Effects of cephaloridine treatment on transport systems of the rat renal brush border membrane. Biochem Pharmacol Life Sci Adv 9:127-133
29. Kuo C-H, Maita K, Sleight SD, Hook JB (1983) Lipid peroxidation: a possible mechanism of cephaloridine-induced nephrotoxicity. Toxicol Appl Pharmacol 63:292-302
30. Linert W, Jameson GNL (2000) Redox reactions of neurotransmitter possibly involved in the progression of Parkinson's disease. J Inorg Biochem 79:319-326
31. Masereeuw R, Russel FGM, Miller DS (1996) Multiple pathways for organic anion excretion in renal proximal tubule revealed by confocal microscopy. Am J Physiol 271:F1173-F1182
32. Mayo JC, Sainz RM, Uria H, Antolin I, Esteban MM, Rodriguez C (1998) Melatonin prevents apoptosis induced 6-hydroxydopamine in neuronal cells: implications for Parkinson's Disease. J Pineal Res 24:179-192
33. Miura D, Miura Y, Yagasaki K (2003) Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats. Life Sci 73:1393-1400
34. Miyasaki JM, Martin W, Suchowersky O, Weiner WJ, Lang AE (2002) Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 58:11-17
35. Monteiro HP, Winterbourn CC (1989) 6-Hydroxydopamine releases in iron from ferritin and promotes ferritin-dependent lipid peroxidation. Biochem Pharmacol 38:4177-4182
36. Morales AI, Buitrago JM, Santiago JM, Fernandez-Tagarro M, Lopez-Novoa JM, Perez-Barriocanal F (2002) Protective effect of trans-resveratrol on gentamicin-induced nephrotoxicity. Antioxid Redox Signal 4:893-898
37. Mapolitano A, Pezzella A, Prota G (1999) New reaction pathways of dopamine under oxidation conditions: nonenzymatic iron-stress conversion to norepinephrine and the neurotoxins 6-hydroxydopamine and 6,7- dihydroxytetrahydroisoquinoline. Chem Res Toxicol 12:1090-1097
38. Nappi AJ, Vass E, Prota G, Memoli S (1995) The effects of hydroxy radical attack on dopa, dopamine, 6-hydroxydopa and 6-hydroxydopamine. Pigment Cell Res 8:283-293
39. Ochu EE, Rothwell NJ, Waters CM (1998) Caspases mediate 6-hydroxydopamine-induced apoptosis but not necrosis in PC12 cells. J Neurochem 70:2637-2640
40. Oldfield FF, Cowan DL, Sun AY (1991) The involvement of ethanol in the free radical reaction of 6-hydroxydopamine. Neurochem Res 16:83-87
41. Plumbo A, Napolitano A, Barone P, d'Ischia M (1999) Nitrite- and peroxide-dependent oxidation pathways of dopamine: 6-nitrodpamine and 6-hydroxydopamine formation as potential contributory mechanisms of oxidative stress- and nitric oxide-induced neurotoxicity in neuronal degeneration. Chem Res Toxicol 12:1213-1222
42. Pritchard JB, Miller DS (1993) Mechanisms of mediating renal secretion of organic anions and cations. Physiol Rev 73:765-796
43. Reiter RJ (1998) Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 56:359-384
44. Sale S, Verschoyle RD, Boocock D, Jones DJ, Wilsher N, Ruparelia KC, Potter GA, Farmer PB, Steward WP, Gescher AJ (2004) Pharmacokinetics in mice and growth-inhibitory properties of the putative chemoprotective agent resveratrol and the synthetic analogue trans 3,4,5,4′-tetramethoxystilbene. Br J Cancer 90:736-744
45. Sato T, Minami S, Okabe T, Igarashi N (1987) Role of renal cathecholamines in the control of sodium and water excretion: lack of natriuresis by endogenous dopamine in the rat kidney. Acta Endocrinol (Copenh) 116:326-332
46. Sekine T, Watanabe N, Hosoyamada M, Kanai Y, Endou H (1997) Expression cloning and characterization of novel multispecific organic anion transporter. J Biol Chem 272:18526-18529
47. Senoh S, Creveling CR, Udenfriend S, Witkop B (1959) Chemical, enzymatic and metabolic studies on the oxidation of dopamine. J Am Chem Soc 81:6236-6340
48. Slotkin TA, Lau C, Kavlock RJ et al. (1988) Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine. J Pharmacol Exp Ther 246:427-433
49. Smith HW, Finkelstein N, Aliminosa L, Crawford B, Graber M (1945) The renal clearance of substituted hippuric acid derivatives and other aromatic acids in dog and man. J Clin Invest 25:388-404
50. Soleas GJ, Grass L, Josephy PD, Goldberg DM, Diamandis EP (2002) A comparison of anticarcinogenic properties of four red wine polyphenols. Clin Biochem 35:119-124
51. Soto-Otero R, Mendez-Alvarez E, Hermida-Ameijeiras A, Munoz-Patino AM, Labandeira-Garcia JL (2000) Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease. J Neurochem 74:1605-1612
52. Thomas GD, Zambrawski EJ (1991) Acute renal function in chronically sympathectomized deoxycorticosterone acetate-treated miniature swine. Proc Soc Exp Biol Med 197:331-336
53. Tune BM (1994) Renal tubular transport and nephrotoxicity of β-lactam antibiotics: structure-activity relationship. Miner Electrolyte Metab 20:221-231
54. Ullrich KJ (1997) Renal transporters for organic anions and cations. Structural requirements for substrates. J Membr Biol 158:95-107
55. Valentovic M, Meadows MK, Harmon RC, Ball JG, Hong SK, Rankin GO (1999) 2-Amino-chlorophenol toxicity in renal cortical slices from Fischer 344 rats: effect of antioxidants and sulfhydryl agents. Toxicol Appl Pharmacol 161:1-9
56. 14C]-trans- resveratrol, a cancer chemoprotective polyphenol, in mouse tissues after oral administration. Life Sci 72:2219-2233
57. Woodgate A, MacGibbon G, Wallon M, Dragunow M (1999) The toxicity of 6-hydroxydopamine on PC12 and P19 cells. Brain Res Mol Brain Res 69:84-92
58. Yousif T, Pooyeh S, Hannemann J, Baumann J, Tauber R, Baumann K (1999) Nephrotoxic and peroxidative potential of meropenem and imipenem/cilastatin in rat and human renal cortical slices and microsomes. Int J Clin Pharmacol Ther 37:475-486
59. Zeewalk, GD, Bernard LP, Nicklas WJ (1998) Role of oxidative stress and the glutathione system in loss of dopamine neurons due to impairment of energy metabolism. J Neurochem 70:1421-1430